Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1503-1507
Published online before print May 4, 2006, doi: 10.1161/01.STR.0000221716.55088.d4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/6/1503    most recent
01.STR.0000221716.55088.d4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bos, M. J.
Right arrow Articles by Breteler, M. M.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bos, M. J.
Right arrow Articles by Breteler, M. M.B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
*Stroke
Related Collections
Right arrow Epidemiology
Right arrow Cerebrovascular disease/stroke
Right arrow Other hypertension
Right arrow Risk Factors for Stroke

(Stroke. 2006;37:1503.)
© 2006 American Heart Association, Inc.


Original Contributions

Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke

The Rotterdam Study

Michiel J. Bos, MD, MSc; Peter J. Koudstaal, MD, PhD; Albert Hofman, MD, PhD; Jacqueline C.M. Witteman, PhD Monique M.B. Breteler, MD, PhD

From the Departments of Epidemiology & Biostatistics (M.J.B., A.H., J.C.M.W., M.M.B.B.) and Neurology (M.J.B., P.J.K.), Erasmus Medical Center, Rotterdam, The Netherlands.

Correspondence to Professor Dr M.M.B. Breteler, Department of Epidemiology & Biostatistics, Erasmus Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands. E-mail m.breteler{at}erasmusmc.nl

Background and Purpose— The role of uric acid as a risk factor for myocardial infarction is controversial, and little is known about its role as a risk factor for stroke. Recent evidence suggests that uric acid may be an important causal agent in cardiovascular disease, for example, by inducing renal disease and hence hypertension. We investigated the association between serum uric acid and coronary heart disease and stroke in a large prospective population-based study.

Methods— The study was based on 4385 participants of the Rotterdam Study who, at baseline (1990 to 1993), were ≥55 years of age, free from stroke and coronary heart disease, and had blood taken. Follow-up for incident stroke and myocardial infarction was complete until January 1, 2002. Data were analyzed with Cox proportional hazards models with adjustment for relevant confounders.

Results— Average follow-up was 8.4 years. High serum uric acid levels were associated with risk of myocardial infarction and stroke; age- and sex-adjusted hazard ratios (95% CIs) for highest versus lowest quintile of uric acid were 1.68 (1.24 to 2.27) for cardiovascular disease (515 cases), 1.87 (1.12 to 3.13) for myocardial infarction (194 cases), 1.57 (1.11 to 2.22) for stroke (381 cases), 1.77 (1.10 to 2.83) for ischemic stroke (205 cases), and 1.68 (0.68 to 4.15) for hemorrhagic stroke (46 cases). Adjustment for other vascular risk factors only slightly attenuated these associations. Associations were stronger in persons without hypertension than in those with hypertension.

Conclusions— Uric acid is a strong risk factor for myocardial infarction and stroke.


Key Words: cerebrovascular disorders • epidemiology • risk factors • stroke • myocardial infarction




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. T. Le, M. Shafiu, W. Mu, and R. J. Johnson
SLC2A9--a fructose transporter identified as a novel uric acid transporter
Nephrol. Dial. Transplant., July 7, 2008; (2008) gfn349v1.
[Full Text] [PDF]


Home page
Arch NeurolHome page
M. A. Schwarzschild, S. R. Schwid, K. Marek, A. Watts, A. E. Lang, D. Oakes, I. Shoulson, A. Ascherio, and and the Parkinson Study Group PRECEPT Investigator
Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
Arch Neurol, June 1, 2008; 65(6): 716 - 723.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Dehghan, M. van Hoek, E. J.G. Sijbrands, A. Hofman, and J. C.M. Witteman
High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes
Diabetes Care, February 1, 2008; 31(2): 361 - 362.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Strasak, E. Ruttmann, L. Brant, C. Kelleher, J. Klenk, H. Concin, G. Diem, K. Pfeiffer, H. Ulmer, and and the VHM&PP Study Group
Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men
Clin. Chem., February 1, 2008; 54(2): 273 - 284.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K.-L. Chien, M.-F. Chen, H.-C. Hsu, W.-T. Chang, T.-C. Su, Y.-T. Lee, and F. B. Hu
Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community
Clin. Chem., February 1, 2008; 54(2): 310 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. K. Kutzing and B. L. Firestein
Altered Uric Acid Levels and Disease States
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. J. Bos, M. J. E. van Rijn, J. C. M. Witteman, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler
Incidence and Prognosis of Transient Neurological Attacks
JAMA, December 26, 2007; 298(24): 2877 - 2885.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. J. Bos, P. J. Koudstaal, A. Hofman, and M. M.B. Breteler
Decreased Glomerular Filtration Rate Is a Risk Factor for Hemorrhagic But Not for Ischemic Stroke: The Rotterdam Study
Stroke, December 1, 2007; 38(12): 3127 - 3132.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. W. Vernooij, M. A. Ikram, H. L. Tanghe, A. J.P.E. Vincent, A. Hofman, G. P. Krestin, W. J. Niessen, M. M.B. Breteler, and A. van der Lugt
Incidental Findings on Brain MRI in the General Population
N. Engl. J. Med., November 1, 2007; 357(18): 1821 - 1828.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Gao, L. Qi, N. Qiao, H. K. Choi, G. Curhan, K. L. Tucker, and A. Ascherio
Intake of Added Sugar and Sugar-Sweetened Drink and Serum Uric Acid Concentration in US Men and Women
Hypertension, August 1, 2007; 50(2): 306 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Cirillo, W. Sato, S. Reungjui, M. Heinig, M. Gersch, Y. Sautin, T. Nakagawa, and R. J. Johnson
Uric Acid, the Metabolic Syndrome, and Renal Disease
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S165 - S168.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. Qiu, B. Winblad, and L. Fratiglioni
Heart Failure, Dementia, and Diuretics: Is Uric Acid Involved?--Reply
Arch Intern Med, November 13, 2006; 166(20): 2287 - 2287.
[Full Text] [PDF]